Status:
COMPLETED
Cognitive Impairment and Imaging Correlates in End Stage Renal Disease
Lead Sponsor:
University of Kansas Medical Center
Conditions:
End Stage Renal Disease
Eligibility:
All Genders
30-75 years
Brief Summary
This is an observational cohort to understand cognitive impairment in end stage renal disease before and after a kidney transplant.
Detailed Description
Cognitive impairment is very common in patients with End Stage Renal Disease (ESRD). It exact mechanisms are not clear, but patients with ESRD have more cerebral white matter changes. Several studies ...
Eligibility Criteria
Inclusion
- Pre-transplant ESRD patients who are listed for renal transplantation
- Able to sign pre-transplant consent on their own will
- Have english as their native language
Exclusion
- Current use of antipsychotics or anti-epileptics
- Inability to read or write which will limit their ability to perform the cognitive tests
- Claustrophobia or inability to get MRI for other reasons
- Unable to sign consent
Key Trial Info
Start Date :
March 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2023
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT01883349
Start Date
March 1 2013
End Date
September 1 2023
Last Update
October 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Kansas Medical Center
Kansas City, Kansas, United States, 66160